Hemostatic Agents Market to reach US$ 5,441.5 Mn by 2025, at a CAGR of 6.4% | Exclusive Report by Fortune Business Insights


You May Also Like

UroGen Reports Fourth Quarter and Full Year 2017 Financial Results

Presentation of MitoGel™ Interim Analysis from OLYMPUS Pivotal Trial in Patients with Low Grade ...

RedHill Biopharma Completes Treatment of Last Patient in BEKINDA® Phase III Study for Acute Gastroenteritis

Top-line results are expected in the second quarter of 2017  The randomized, double-blind, placebo-controlled Phase III study ...